Standard Dose of Ibrutinib is Effective in the Treatment of Bing-Neel Syndrome

Pathol Oncol Res. 2020 Jan;26(1):591-592. doi: 10.1007/s12253-018-0482-9. Epub 2018 Oct 25.

Authors

Mark Plander¹, Tamás Szendrei², Árpád Vadvári³, János Iványi²

Affiliations

¹ Department of Haematology, Markusovszky University Teaching Hospital, Markusovszky str 5., Szombathely, 9700, Hungary. planderm@yahoo.com.
² Department of Haematology, Markusovszky University Teaching Hospital, Markusovszky str 5., Szombathely, 9700, Hungary.
³ Department of Radiology, Markusovszky University Teaching Hospital, Szombathely, Hungary.

PMID: 30357751
DOI: 10.1007/s12253-018-0482-9

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenine / analogs & derivatives
Antineoplastic Agents / therapeutic use*
Central Nervous System Neoplasms / diagnostic imaging
Central Nervous System Neoplasms / drug therapy*
Central Nervous System Neoplasms / pathology
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Piperidines
Pyrazoles / therapeutic use*
Pyrimidines / therapeutic use*
Treatment Outcome
Waldenstrom Macroglobulinemia / diagnostic imaging
Waldenstrom Macroglobulinemia / drug therapy*
Waldenstrom Macroglobulinemia / pathology

Substances

Antineoplastic Agents
Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Adenine